OneDigital Investment Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,310
Closed -$161K 1404
2024
Q3
$161K Sell
12,310
-4,000
-25% -$60.9K ﹤0.01% 1378
2024
Q2
$229K Sell
16,310
-50
-0.3% -$815 ﹤0.01% 1232
2024
Q1
$276K Sell
16,360
-3,000
-15% -$44.7K ﹤0.01% 937
2023
Q4
$273K Sell
19,360
-28
-0.1% -$329 ﹤0.01% 946
2023
Q3
$200K Buy
+19,388
New +$260K ﹤0.01% 941

Other funds holding AVDL

OneDigital Investment Advisors's AVDL Position: Q4 2024 in Review

OneDigital Investment Advisors sold out of Avadel Pharmaceuticals (AVDL) in Q4 2024, closing a stake of 12,310 shares — an estimated $161K sold.

OneDigital Investment Advisors first reported a position in AVDL in Q3 2023 and held it in 5 quarters. The position peaked at $276K in Q1 2024. 159 funds tracked by Wall St. Rank hold AVDL as of Q4 2024.

  • OneDigital Investment Advisors reported no remaining Avadel Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • OneDigital Investment Advisors sold 12,310 Avadel Pharmaceuticals shares in Q4 2024, an estimated $161K.
  • OneDigital Investment Advisors first reported a position in Avadel Pharmaceuticals in Q3 2023 and held it in 5 quarters.
  • OneDigital Investment Advisors's Avadel Pharmaceuticals position peaked at $276K in Q1 2024.
  • 159 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2024.

Based on OneDigital Investment Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.